Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10035966HBVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS30067436HIVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061554HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061565HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061861HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS44008599HTLV-1ENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS44039492HTLV-1ENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TCGA Plot Options
Drug Information
GeneABCB1
DrugBank IDDB00778
Drug NameRoxithromycin
Target IDBE0001032
UniProt IDP08183
Regulation Type
PubMed IDs16595573; 17164692
CitationsBeltinger J, Haschke M, Kaufmann P, Michot M, Terracciano L, Krahenbuhl S: Hepatic veno-occlusive disease associated with immunosuppressive cyclophosphamide dosing and roxithromycin. Ann Pharmacother. 2006 Apr;40(4):767-70. Epub 2006 Mar 7.@@Kaufmann P, Haschke M, Torok M, Beltinger J, Bogman K, Wenk M, Terracciano L, Krahenbuhl S: Mechanisms of venoocclusive disease resulting from the combination of cyclophosphamide and roxithromycin. Ther Drug Monit. 2006 Dec;28(6):766-74.
GroupsApproved; Investigational; Withdrawn
Direct ClassificationAminoglycosides
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
PathwaysRoxithromycin Action Pathway
PharmGKBPA164750505
ChEMBLCHEMBL1214185